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Abstract
Background
It has been advocated that older adults should concomitantly spend less time in sedentary
behaviour (SB), and engage in sufficient physical activity (PA), to reduce their risk of cardio-
metabolic diseases. However, it is not clear what intensity of PA must be done to offset SB
engagement.
Aim
Model how cardio-metabolic profiles could change if older adults replaced an hour per day
(hr�day-1) of a physical behaviour intensity with 1 hr�day-1 of another physical behaviour of a
different intensity.
Methods
Older adults (n = 93, 60–89 years old, 55% female) wore a thigh-mounted triaxial accelerom-
eter for seven consecutive free-living days to estimate mean daily hourly engagement in SB,
Standing, Light Intensity PA (LIPA), sporadic moderate to vigorous physical activity (sMVPA,
bouts <10 continuous minutes), and 10-minute MVPA (10MVPA, bouts�10 continuous min-
utes. Fasting whole blood concentration of plasma glucose, triglyceride, total cholesterol, and
glycated haemoglobin (%), along with serum concentration of lipoprotein lipase (LPL), inter-
leukin-6 (IL-6), and procollagen III N-terminal propeptide (PIIINP) were measured.
Results
Isotemporal Substitution, with covariate adjustment, suggested that: total cholesterol con-
centration could theoretically decrease when 1 hr�day-1 of SB is replaced with Standing,
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when 1 hr.day-1 of LIPA is replaced with Standing, and when 1 hr�day-1 of sMVPA is
replaced with Standing. Triglyceride concentration theoretically decreased when 1 hr�day-1
of SB, Standing, LIPA, or sMVPA is replaced with 10MVPA. Triglyceride concentration theo-
retically increases when 1 hr�day-1 of 10MVPA is replaced with SB, Standing, or LIPA. No
associations with time reallocation appears to exist for LPL, HbA1c, IL-6, and PIIINP.
Conclusion
The type of physical behaviour being replaced could be crucial for total cholesterol mainte-
nance. Engagement in 10MVPA could be necessary to improve triglyceride concentration.
Introduction
In the past, attitudes to physical activity recommendation for older adults was simply that
“some physical activity is better than none” [1]. More recently, guidelines have been more
detailed so that in the United Kingdom for instance, the recommendations are that older
adults should engage in at least 150 minutes per week of moderate to vigorous physical activity
(MVPA) through the accumulation of bouts of at least 10 minutes (10MVPA) [1]. Reaching
this target is thought to reduce the risk of cardiovascular mortality by 35% [2]. However based
on objective monitoring of physical behaviour within older adult cohorts, where cardiovascu-
lar disease is one of the leading causes of death [3], less than 15% of the population are thought
to attain the 150 minutes per week 10MVPA target [4, 5]. With such low attainment rates for
the 10MVPA recommendation within older adult populations, it is pertinent to find and advo-
cate, alternative physical behaviour interventions that could improve cardiovascular health for
adults who do not or cannot attain the 10MVPA recommendation.
Epidemiological studies have suggested that physical behaviour at intensities below MVPA
could modulate cardiovascular disease risk factors, such as plasma triglycerides and glucose
[6–8]. However, implementation of these findings by end-users would require a change in
their habitual physical behaviour profile that, in a 24-hour day, would reduce the amount of
time they could spend engaging in other physical behaviours. Ultimately, physical behaviour
change is not just about the newly engaged physical behaviour but also about the physical
behaviour that is being replaced, and the collective effects that the changes in these two physi-
cal behaviour intensities have on health status. Until recently, physical behaviour epidemiology
had failed to account for the time limiting impact of a 24-hour day when predicting how a
change in a physical behaviour may affect health status.
Isotemporal Substitution Modelling is a relatively new form of statistical analysis within PB
research, first used to predict weight change in middle-aged women (25–42 years) [9]. Since
this seminal research, 80 publications have utilised ISM (PubMed, retrieved 26/02/2019).
However, there is an apparent lack of studies that examine the associations between time real-
location and cardio-metabolic profile in older adult populations [10].
The adoption of isotemporal substitution modelling (ISM) [9] by physical behaviour
researchers has now made it possible to determine how health status may be affected by replac-
ing the time spent engaging in one physical behaviour intensity with another physical behav-
iour intensity. The growing evidence base of ISM has highlighted that as little as a 10-minute
change in physical behaviour profile can affect cardio-metabolic status [11–20]. However, pre-
vious ISM studies have ‘objectively’ estimated the engagement in the physical behaviour spec-
trum with hip, waist, or wrist mounted accelerometers, which are arguably less accurate in
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terms of classifying posture and thus, cannot reliably distinguish between sedentary behaviour
(SB) and standing, for instance, which have shown to have opposing effects on health status
[12, 21–23].
Thus, the aim of the current cross-sectional study was to model how older adults’ cardio-
metabolic endocrine profiles would change if they replaced an hour per day (1 hr�day-1) of a
physical behaviour intensity with 1 hr�day-1 of another physical behaviour of a different inten-
sity (e.g. replace SB with light intensity physical activity [LIPA]). It was hypothesised that
replacing 1 hr�day-1 of physical behaviour for one of a higher intensity (in terms of metabolic
demands) would improve cardio-metabolic status and vice versa.
Materials and methods
Ethical approval was granted by the Manchester Metropolitan University Exercise and Sports
Science Ethics Sub-Committee (Approval Code: 03.11.14(i)). Written informed consent was
provided by all participants prior to data collection. Participants were recruited from older
adult community groups (e.g. Bridge clubs and Bowls clubs) within a rural, affluent, and highly
educated county in England [24, 25] Older adults (� 60 years old) were eligible for the study if
they were independently mobile (did not require walking aids), were not diabetic, had no cur-
rent/past history of neurological disorders likely to limit mental/physical function at the time
of the study, were not suffering from an un-treated cardiovascular disease. Ninety-three older
adults (73.8 ± 6.23 years, 60–89 years, 55% female) were recruited between January 2015 and
June 2016. Participants visited the laboratory on two occasions, separated by at least seven
days.
First laboratory visit
During the first laboratory visit, participants were familiarised with the testing protocol that
they would undergo during the second laboratory visit. Demographic information, such as
height, weight, and current medical prescriptions were also collected. Medication use was pre-
sented in the following formats: the number of different medications prescribed for daily use,
which could directly influence cardiovascular profile (Directly CVD Meds [n�day-1]), the num-
ber of different medications prescribed for daily use, which could (in)directly influence cardio-
vascular profile ((In)directly CVD Meds [n�day-1]), the sum daily dosage of inflammatory, (in)
directly influencing cardiovascular profile medication (CVD Meds [mg�day-1]), daily dose of
blood pressure medication (BP Meds [mg�day-1]), daily dose of lipid-lowering medication
(Lipid-Lowering Meds [mg�day-1]).
Participants were fitted with a thigh-mounted triaxial accelerometer (GENEActiv Original,
Activinsights Ltd, Kimbolton, UK) on the dominant leg (anterior aspect, 50% of greater tro-
chanter to femoral condyle distance) using two waterproof adhesive patches (3M Tegaderm
Film, North Ryde, Australia) to be worn for seven consecutive free-living days. The full details
of the accelerometer programming can be found in [26]. Briefly, an in-house developed data
analysis software (the Cheshire Algorithm for Sedentarism [CAS]) [27] utilised 60 Hertz sam-
pling frequency, 10 second epoch accelerometer data to determine participant time spent in
SB (seated or reclined posture,�1.5 Metabolic Equivalent Tasks [METs]), Standing (upright
posture,�1.5 METs), LIPA (upright posture 1.5–3.0 METs), Sporadic MVPA (sMVPA,
upright posture,�3.0 METS, for<10 consecutive minutes), and 10MVPA (upright posture,
�3.0 METS, for�10 consecutive minutes. Nighttime sleeping hours (i.e. daytime naps not
included) was self-reported using a written sleep-diary and included within CAS analysis.
Where sleeping hours was not reported, raw accelerometer data was cross-referenced to iden-
tify prolonged nocturnal reclined posture. Thus, an estimate of when a participant went to bed
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and woke up on the monitored week was always possible. Three participants were removed
from analysis for having <6 days of accelerometer data.
Second laboratory visit
Participants arrived at the laboratory in an overnight (>10 hours) fasted, hydrated state. Par-
ticipants refrained from taking medication on the morning of the laboratory visit until the
completion of a 10 mL venous blood sample donation. Hydration, medication intake and a
light breakfast were then allowed immediately after said sampling.
Whole blood cardio-metabolic analysis
Immediately following blood donation (i.e. within 3 mins), whole blood analyses of total cho-
lesterol, triglyceride, glucose, and glycated haemoglobin (HbA1c, sub-sample of n = 33) using
three Accutrend Plus monitor devices and test strips (Roche Diagnostics Limited, Welwyn
Garden City, UK) and one HemoCue 501 device and test cartridge (HemoCue, A¨ngelholm,
Sweden), respectively, were carried out. Analyses were performed in triplets and averaged for
total cholesterol, triglyceride, and glucose whereas only a single sample was analysed for
HbA1c. Accutrend monitors have shown no difference in comparison to clinical laboratory
methods in the measurement of total cholesterol, triglyceride, and glucose concentration [28].
Furthermore, the HemoCue 501 has shown good reliability (Coefficient of Variation [CV] <5/
0%) and validity (Bland-Altman: 4.4 [95%CI -7.3, 16.2] mmol�mol-1) compared to high perfor-
mance liquid chromatography ion exchange [29]
The remainder of the whole blood sample was allowed to clot whilst placed on crushed ice
in a 10 mL Serum Vacutainer (Becton Dickinson, New Jersey, USA) for less than two hours
before centrifugation at 1687 G for five minutes (Z380, Hermle, Gosheim, Germany). Serum
was extracted into 1.0 mL aliquots (Eppendorf Ltd, Hamburg, Germany) and stored at -20 ºC
until further analyses.
Serum cardio-metabolic analyses
Concentration of serum lipoprotein lipase (LPL), procollagen III N-terminal propeptide
(PIIINP), and interleukin-6 (IL-6) were determined using commercially available enzyme-
linked immunosorbent (ELISA) assay kits (LPL: Cell Biolabs Inc., California, USA, PIIINP:
Biomatik, Delaware, USA, IL-6: high-sensitivity, Bio-Techne, Minnesota, USA) with a two-
fold sample dilution. Manufacturer intra-assay sample CV was 4% (<13% in-house) for LPL,
<10% (6.5–9.6% in-house) for PIIINP, and 7.8% (7.4–9.2% in-house) for IL-6. A 96-well spec-
trophotometer (EL808, BioTek, Vermont, USA) connected to a computer running Gen5 c
1.11 software (BioTek, Vermont, USA) was used to derive protein concentration data.
Statistical analyses
SPSS version 22 (IBM, New York, USA) was used for statistical modelling. Physical behaviour
parameters, measured in mean hrs�day-1 (SB, Standing, LIPA, sMVPA, and 10MVPA) and the
summation of these parameters (Total PB) were used for ISM. Pearson correlation was used to
assess multicollinearity between physical behaviour parameters and total PB; no adjustment to
the data was made if multicollinearity was present. The largest case of collinearity was between
SB and LIPA (r2 = -0.69), which was below the suggested limits of collinearity (r2>0.9) [30].
To illustrate the effect on cardio-metabolic parameters with the replacement of one hour of a
physical behaviour with another, the replaced physical behaviour parameter was removed
from the linear regression model (forced entry) (i.e. replace SB model: Intercept + (β1 x
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Standing) + (β2 x LIPA) + (β3 x sMVPA) + (β4 x 10MVPA) + (β5 x Total PB) + Covariates
+ Error) [30]. Significant predictors in the model illustrate that the replacement of a physical
behaviour with the significant physical behaviour could have a predicted effect on the cardio-
metabolic parameter. To standardise reporting of the ISM outcome, the removed physical
behaviour is mentioned first. For example, ‘the replacement of one hour of SB with standing
reduced total cholesterol’ means that SB engagement has been reduced by one hour and
replaced with one hour of standing.
ISM was performed without (Model 1) and with (Model 2) covariate adjustment (Directly
CVD Meds [n�day-1], [In]directly CVD Meds [n�day-1], CVD Meds [mg�day-1], BP Meds
[mg�day-1], Lipid-Lowering Meds [mg�day-1]). A covariate was included in the ISM if a forced
entry linear regression model had highlighted an association between the covariate and the
respective cardio-metabolic parameter in a preliminary analysis of the dataset. These covari-
ates were chosen as they have previously been shown to influence the cardio-metabolic param-
eters of interest in the current study [31–34]. Cardio-metabolic data were naturally LOG
transformed if they violated normal distribution (total cholesterol, triglyceride, LPL, IL-6, and
PIIINP). Data are presented as beta coefficient (95% Confidence Interval [CI]) unless stated
otherwise. Statistical significance was set at p�0.05.
Results
To enhance reader experience, this study features augmented reality. To access this feature,
please download HP Reveal (Hewlett-Packard, California, USA) from your smart phone app
store and create a free account. Search for, then follow DrDeclanRyan, scan your phone cam-
era over the figures within this study to view the augmented reality attachments.
The sample population characteristics are detailed below (Table 1). Over 50% of the sample
population had lipid markers that were above international recommended thresholds (triglyc-
eride: 56%, total cholesterol: 66%). Whilst for glucose markers, 35% of the sample population
had a higher than recommended glucose concentration but no participants had an above
threshold HbA1c percentage. Twenty-one percent of the participants were not prescribed
medication, whilst 30% and 60% of the population had been prescribed lipid-lowering and
blood pressure medication, respectively. Notably, mean 10MVPA was below 10 mins�day
-1
(Table 1), this was because 49 participants failed to register a single bout of 10-continuous
minutes of MVPA across seven-days of monitoring.
It is pertinent to note that for simplicity, only significant models are presented in the results
section. The complete set of the results is displayed in the Supporting Information (S1–S7
Tables). Significant ISM was present for total cholesterol and triglyceride (Figs 1 and 2) i.e. two
out of a possible seven cardio-metabolic markers that were monitored.
Total cholesterol
Without covariate adjustment, the replacement of 1 hr�day-1 of SB with standing was associated
with a reduction in total cholesterol by (anti-logged data) 1.14 (95%CI 1.28, 1.01) mmol�l-1 (Fig
1). This is clinically relevant as a 0.5 mmol�l-1 decrease in total cholesterol concentration is asso-
ciated with a 17% decreased risk in coronary heart disease mortality [35]. The replacement of
LIPA with standing was associated with a reduction in total cholesterol (anti-logged data, 1.25
[95%CI 1.49, 1.04] mmol�l-1) (Fig 1). Finally, the replacement of sMVPA with standing was
associated with a reduction in total cholesterol by (anti-logged data) 1.15 (95%CI 1.32, 1.01)
mmol�l-1 (Fig 1). With adjustment for directly CVD medication (n�day-1) and (in)directly CVD
medication (n�day-1), all significant models (model 1) remained significant (model 2) (Fig 1).
Predicting changes in older adults’ cardio-metabolic profiles by modelling physical behaviour change
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Triglyceride
There were no covariates for triglyceride. Most notably, the replacement of any PB with
10MVPA was associated with a decrease in triglyceride concentration by similar amounts, as
the change in triglyceride concentration fell between (anti-logged data) 1.89–2.03 (95%CI
range: 3.16, 1.17) mmol�l-1 (Fig 2). On the other hand, the replacement of 10MVPA with any
other PB (excluding sMVPA) was associated with an increase in triglyceride concentration by
similar amounts (anti-logged data, beta coefficient range: 1.79–1.86 [95%CI range: 1.17, 2.94])
mmol�l-1 (Fig 2). These results are clinically relevant as a 1.0 mmol�l-1 increase in triglyceride
concentration is associated with a 14% (95%CI 5, 28%, male) - 37% (95%CI 13, 66%, female)
relative risk increase in CVD prevalence [36].
Table 1. Participant demographics for the study sample. Displayed as Mean (Standard Deviation) unless stated
otherwise.
Variable Pooled Population
n 93
Female (%) 55
Age (years) 73.8 (6.22)
Height (m) 1.65 (0.08)
Mass (kg) 75.9 (13.1)
BMI (kg�m2) 27.9 (4.71)
Covariates
Directly CVD Meds (n�day-1)† 1.17 (1.52)
(In)directly CVD Meds (n�day-1)‡ 1.62 (1.81)
Inn+ (In)directly CVD Meds (mg�day-1)¥ 157.86 (486.49)
BP Meds (mg�day-1) 9.81 (50.79)
Lipid-Lowering Meds (mg�day-1) 8.12 (16.58)
Cardio-metabolic Parameters
Triglyceride (mmol�l-1) 1.77 (0.81)m
Total Cholesterol (mmol�l-1) 5.44 (1.39)m
Glucose (mmol�l-1) 5.72 (1.10)m
HbA1c (%) 5.29 (0.31)
LPL (pg�mL-1) 113.02 (147.80)m
IL-6 (pg�mL-1) 2.72 (2.77)m
PIIINP (pg�mL-1) 229.21 (247.97)m
Physical Behaviour Parameters
SB (hrs�day-1) 9.65 (1.33)
Standing (hrs�day-1) 1.09 (0.41)
LIPA (hrs�day-1) 1.97 (0.63)
sMVPA (hrs�day-1) 2.57 (0.64)
10MVPA (hrs�day
-1) 0.08 (0.20)m
Total PB (hrs�day-1) 15.4 (4.77)m
† Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. statins,
warfarin)
‡ Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a
side effect
¥ Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a
side effect, including inflammatory medication. m Median (IR).
https://doi.org/10.1371/journal.pone.0224223.t001
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Discussion
The objective of this study was to mathematically model, using ISM, how a strictly older adult
population (60–89 years) could change their cardio-metabolic profile through changes in PB
engagement. It was hypothesised that substitution of SB or PA with PA of higher intensity may
theoretically improve cardio-metabolic profile whilst the substitution of a higher intensity PA
with a lower intensity PA or SB would theoretically worsen cardio-metabolic profile, as has
been illustrated previously in young-middle and middle-older adult populations [11, 12, 14].
Indeed the hypotheses were confirmed as the replacement of SB with standing was associated
Fig 1. Significant changes in total cholesterol concentration with the replacement of 1 hr�day-1 of PB with
another. Model 1: no covariate adjustment. Model 2: adjusted for directly CVD medication (n�day-1) and (in)directly
CVD medication (n�day-1). Data points represent LOG data (from left to right): -95%CI, beta coefficient, +95%CI.
p�0.05. This figure is Augmented Reality Ready, download HP Reveal from your Smart Phone App Store to access the
embedded videos.
https://doi.org/10.1371/journal.pone.0224223.g001
Fig 2. Significant changes in triglyceride concentration with the replacement of 1 hr�day-1 of PB with another.
Model 1: no covariate adjustment. Data points represent LOG data (from left to right): -95%CI, beta coefficient, +95%
CI. p�0.05. This figure is Augmented Reality Ready, download HP Reveal from your Smart Phone App Store to access
the embedded videos.
https://doi.org/10.1371/journal.pone.0224223.g002
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with a decrease in total cholesterol concentration and the replacement of any PB with 10MVPA
was associated with a decrease in triglyceride concentration. Therefore, the results of the cur-
rent study suggested that using PB interventions could be a useful method for the prevention
and treatment of lipid disorders, such as atherosclerosis, which when it manifests in the coro-
nary arteries, is responsible for 44.5% of CVD deaths in UK older adults [3]. However, at face
value, some of the total cholesterol results were counterintuitive as the replacement of sMVPA
and LIPA with standing was, in fact, associated with a decrease in total cholesterol
concentration.
The two sides to standing
Total cholesterol is comprised of high-density lipid cholesterol (HDL-C), low-density lipid
cholesterol (LDL-C), and triglyceride. The theoretical reduction in total cholesterol concentra-
tion, after sMVPA and LIPA were replaced with standing in the current model, may be a prod-
uct of lowered HDL-C, thereby suggesting that standing negatively affects cardio-metabolic
status. Indeed, one month of detraining following a LIPA intervention in older adults (mean
age 75.5±5.60 years) has been reported to decrease HDL-C concentration whilst LDL-C and
triglyceride remained constant [37].
Not only did the modelled replacement of sMVPA and LIPA with standing theoretically
reduce total cholesterol within the current study but a decrease in total cholesterol concentra-
tion was also associated with SB being replaced with standing. It could be postulated that
standing is positively affecting lipoprotein profile in this case, possibly by reducing non
HDL-C lipoproteins. This postulation is in agreement with a previous four-day intervention
study in young adults (21±2 years), which found non-HDL-C concentration decreased from
2.94±0.47 to 2.65±0.48 mmol�l-1 following the replacement of six hours of SB with two hours
of standing and four hours of walking, compared to a 14 hrs�day-1 of SB day [23]. Meanwhile,
there was also a non-significant trend for total cholesterol to decrease from 4.20±0.67 to 3.96
±0.50 mmol�l-1 (p = 0.17) [23]. Although ISM can suggest an intervention, it cannot state how
long an intervention can take to have a significant effect on health status. However, along with
the results of Duvivier, Schaper [23], it could be suggested that the replacement of one hour of
SB with standing could reduce total cholesterol if the intervention lasts longer than four days.
Overall, these findings suggested that standing could affect circulating cholesterol, differen-
tially, depending on which PB parameter it is displacing and thus facilitates the prediction of
individualised outcomes for PB change interventions.
Benefits of prolonged moderate activity
Performing longer bouts of MVPA may induce a chronic physiological effect that protects
against physical inactivity, as total cholesterol concentration modelling was predicted to
decrease when sMVPA, but not 10MVPA, was replaced with standing within the current study.
In terms of the time frame for adaption in cholesterol profile with the introduction of physical
inactivity, previous studies have varied considerably depending on what duration of MVPA
bouts were being undertaken prior to physical inactivity. For example, the lipoprotein profile
of trained endurance rowers took 29 weeks, following the cessation of exercise (performed in
bouts of MVPA�10 mins), to become significantly different. Specifically, HDL-C decreased
from 0.92±0.09 pre detraining to 0.81±0.11 mmol�l-1 post detraining (p<0.05, a 0.004 mmol�l-1
reduction per week) [38]. Whereas, it took only four weeks until HDL-C concentration was
significantly reduced (from 1.42±0.05 to 1.34±0.05 mmol�l-1, p<0.05, a 0.02 mmol�l-1 reduc-
tion per week) following the cessation of a four-month interval training intervention (per-
formed in bouts of MVPA <10 mins, 4 × 4 mins MVPA, 3 mins rest) [39]. Despite these
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previous finding being reported in middle-aged adults, there are similarities in cardio-meta-
bolic change with a reduction in MVPA when compared with the current study. It is likely
that engagement in prolonged bouts of MVPA (10MVPA) would be beneficial in the preserva-
tion of long-term cholesterol profile should an older adult be temporarily forced into a physi-
cally inactive lifestyle (i.e. prolonged bedrest due to illness or injury).
Furthermore, the associated reduction in fasted triglyceride concentration when any PB,
including sMVPA, was replaced with 10MVPA in the current study, also strengthens the theo-
rem that prolonged MVPA bouts would improve/maintain lipoprotein profile. In addition, the
lack of association on fasted triglyceride concentration when SB was replaced for PA suggests
that a focus on reducing physical inactivity is more important than SB reduction when
attempting to improve triglyceride profile. Whereas the lack of effect on fasted total cholesterol
when 10MVPA is replaced in the model (and improvements when SB is replaced) could sug-
gest that SB reduction as opposed to physical inactivity reduction could be more important for
total cholesterol profile improvements, possibly due to the effects on LDL-C and HDL-C path-
way alluded to above. However, intervention studies would be required to confirm or deny the
hypotheses engendered through the present modelling exercises.
No effect of physical behaviour on lipoprotein lipase
Pre-heparin serum LPL concentration was measured within the current study and it is thought
to represent whole-body LPL production and the systemic potential to hydrolyse triglycerides
[40, 41]. Additionally, pre-heparin serum LPL has been shown to be inversely related to the
progression of coronary artery disease in young/middle–older aged populations (Hitsumoto,
Ohsawa [42]: 22–79 years, Rip, Nierman [43]: 45–79 years), highlighting that pre-heparin
serum LPL is anti-atherogenic. Furthermore, exercise has been shown to increase LPL within
humans and rats in all age groups [44–46], thus suggesting that PA can protect against athero-
sclerosis through the mediation of the LPL pathway. Conversely, the results of the current
modelling study suggested that the replacement of any PB may not necessarily affect serum
LPL concentration. A possible explanation for these results is that pre-heparin serum LPL is
representative of whole-body LPL [40, 41], in which, the expression of LPL within certain sites
can portray a pro-atherogenic effect (e.g. artery wall) [47]. Therefore, the representation of
both pro and anti-atherogenic LPL within pre-heparin serum LPL may cause ‘noise’ within the
ISM, thus nullifying any effects on pro or anti-atherogenic LPL that may exist with PB change.
Furthermore, this ‘noise’ is likely to be more pronounced in the older adult population, who
already have an increased serum LPL concentration compared to middle aged adults [48] and
are more likely to show progression of atherosclerosis, which has been positively associated
with LPL concentration within the aorta [49].
Not statistically significant but clinically significant results
Although the confidence interval range of some of the cardio-metabolic markers suggested no
association with PB substitution, there were beta co-efficients and confidence intervals that
were large enough to suggest some clinical relevance. Previous findings from Emerging Risk
Factors Collaboration [50] suggested that a 1 mmol�l-1 increase in fasting plasma glucose was
associated with a 12% increase in hazard ratio for coronary heart disease incidents. Within the
findings of the current study, replacing 10MVPA with SB had a beta-coefficient of 0.38 mmol�l
-
1 and an upper confidence interval limit of 2.04 mmol�l-1 (S4 Table). This may suggest that
some older adults will experience adverse effects of replacing 10MVPA with SB. It could be that
the design of this study may not have been sufficient to detect statistically significant associa-
tions, but it should not mean that future studies dismiss further research.
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Strengths and limitations
The current study’s strength include the utilisation of a week-long thigh-mounted accelerome-
ter to accurately detect all physical behaviours including sedentary behaviour, every 60 sec-
onds. Another strength was the fact that the accelerometers were thigh mounted which
allowed for the investigation of standing; a physical behaviour which has shown mixed results
in randomised cross-over trials in terms of its impact on cardio-metabolic profile during pro-
longed sitting [22, 23, 51, 52]. Furthermore, the physical behaviour data in our study has
allowed the investigation of the importance of the 10-minute criterion for MVPA, which is a
current discussion point within the UK physical activity guidelines. Finally, the utilisation of
isotemporal substitution analysis is essentially mathematical modelling of potentially effective
physical behaviour change guidance, ultimately useful to both practitioners and end-users, as
such analyses may assist with individualising physical behaviour programmes. It is neverthe-
less noted that given the cross-sectional study design, the presence of reverse causality bias for
instance, cannot be ruled out. In addition to this, as this study was performed on a relatively
small sample, some of the analysis may have been under-powered, increasing the chance of a
type II error. An unsurmountable study limitation in this cross-sectional study design, was the
fact that we could not stop participants taking pre-existing medications and indeed it would
have been unrealistic and unrepresentative of an older population to have only recruited older
persons on zero phamaceuticals. Whilst we applied statistical adjustment to this limitation by
treating medication use as a covariate, the fact that we reduced this data to the categorical level
means that the precision of our adjustment was limited. Future research should conduct this
modelling with longitudinal data of a larger older adult sample size. We also recommend that
future studies be statistically powered to recruit samples large enough to have sufficient num-
bers of participants using similar drug therapies. In this way, the amount and type of medica-
tion can be recorded and thus used at the ratio/interval level, thereby improving on the quality
of adjustments.
Conclusion
The current study added further evidence to support the 10-minute bout recommendation
within the MVPA guidelines of PA for older adults, as well as highlighting that quantitative
guidelines are required for reducing SB engagement in older adults. Finally, the current study
has potentially shown that a PB can have both a positive and negative effect on cardio-meta-
bolic status (though requiring further investigation), dependent on what PB it is replacing.
Thus, advocating the need for individualised interventions, where possible, that account for
the participant’s habitual PB engagement, rather than a one size fits all approach.
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